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Abstract
Background: Disability-adjusted life years (DALYs) provide a summary measure of health and can be a critical input
to guide health systems, investments, and priority-setting in Ethiopia. We aimed to determine the leading causes of
premature mortality and disability using DALYs and describe the relative burden of disease and injuries in Ethiopia.
Methods: We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) for
non-fatal disease burden, cause-specific mortality, and all-cause mortality to derive age-standardized DALYs by sex
for Ethiopia for each year. We calculated DALYs by summing years of life lost due to premature mortality (YLLs) and
years lived with disability (YLDs) for each age group and sex. Causes of death by age, sex, and year were measured
mainly using Causes of Death Ensemble modeling. To estimate YLDs, a Bayesian meta-regression method was used.
We reported DALY rates per 100,000 for communicable, maternal, neonatal, and nutritional (CMNN) disorders,
non-communicable diseases, and injuries, with 95% uncertainty intervals (UI) for Ethiopia.
Results: Non-communicable diseases caused 23,118.1 (95% UI, 17,124.4–30,579.6), CMNN disorders resulted in
20,200.7 (95% UI, 16,532.2–24,917.9), and injuries caused 3781 (95% UI, 2642.9–5500.6) age-standardized DALYs
per 100,000 in Ethiopia in 2015. Lower respiratory infections, diarrheal diseases, and tuberculosis were the top
three leading causes of DALYs in 2015, accounting for 2998 (95% UI, 2173.7–4029), 2592.5 (95% UI, 1850.7–3495.1), and
2562.9 (95% UI, 1466.1–4220.7) DALYs per 100,000, respectively. Ischemic heart disease and cerebrovascular disease
were the fourth and fifth leading causes of age-standardized DALYs, with rates of 2535.7 (95% UI, 1603.7–3843.2) and
2159.9 (95% UI, 1369.7–3216.3) per 100,000, respectively. The following causes showed a reduction of 60% or more
over the last 25 years: lower respiratory infections, diarrheal diseases, tuberculosis, neonatal encephalopathy, preterm
birth complications, meningitis, malaria, protein-energy malnutrition, iron-deficiency anemia, measles, war and legal
intervention, and maternal hemorrhage.
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Conclusions: Ethiopia has been successful in reducing age-standardized DALYs related to most communicable,
maternal, neonatal, and nutritional deficiency diseases in the last 25 years, causing a major ranking shift to
types of non-communicable disease. Lower respiratory infections, diarrheal disease, and tuberculosis continue
to be leading causes of premature death, despite major declines in burden. Non-communicable diseases also
showed reductions as premature mortality declined; however, disability outcomes for these causes did not
show declines. Recently developed non-communicable disease strategies may need to be amended to focus
on cardiovascular diseases, cancer, diabetes, and major depressive disorders. Increasing trends of disabilities
due to neonatal encephalopathy, preterm birth complications, and neonatal disorders should be emphasized
in the national newborn survival strategy. Generating quality data should be a priority through the development of
new initiatives such as vital events registration, surveillance programs, and surveys to address gaps in data. Measuring
disease burden at subnational regional state levels and identifying variations with urban and rural population health
should be conducted to support health policy in Ethiopia.
Keywords: Disability-adjusted life years, Communicable disease, Maternal and neonatal disease, Nutritional deficiency
disorders, Non-communicable diseases, Injuries, Ethiopia
Background
Like many other countries in sub-Saharan Africa,
Ethiopia is a country of diverse cultures, traditions, and
histories [1]. In spite of its ancient civilizations, Ethiopia
is still one of the least developed countries, with low de-
velopment indicators; according to The World Bank
report, Ethiopia’s GNI was 590 USD per capita in 2015 [2,
3]. Following its economic progress in the last decades,
Ethiopia anticipates joining the category of lower-middle-
income countries by 2025, and upper-middle-income
countries by 2035 [4]. The pyramidal age structure of the
population has remained predominately young, with
44.9% under the age of 15 years, and over half (52%) of
the population between the ages of 15–65 years; 3% of the
population was over the age of 65 years [5]. The total
population for Ethiopia in 2015 was estimated at 90 mil-
lion [2]. The average fertility trend in recent years has
shown significant decline from the 2000 level of 5.5 births
to 4.6 births per woman in 2015, but is still nearly twice
the world average [6, 7].
In 2015, the Ethiopian health sector finalized its 20-
year National Health Sector Development Program
(HSDP), focusing on decentralizing and expanding the
primary health care system, and encouraging the partici-
pation of non-governmental partners [1, 8]. During the
20-year period, the country has shown remarkable pro-
gress implementing high-impact health interventions
through its flagship community-focused program known
as the “Health Extension Program” [8]. For instance,
under-5 mortality has decreased by two-thirds, [9] and
the maternal mortality ratio decreased from 708 in 1990
to 497.4 in 2013 [10]. Moreover, the estimated average
life expectancy at birth increased from 45.5 years in
1990 to 61.7 years in 2013 [11].
Following the HSDP, in 2015, Ethiopia started to
implement the Health Sector Transformation Plan
(HSTP), a five-year strategic plan to improve the
quality and equity of health services and universal
health coverage [2].
Obtaining reliable data to measure the progress made
with the previous HSDP plan and set benchmarks for
HSTP, however, is challenging for Ethiopia. As a result,
in setting policy framework and envisioning targets, the
country has used different scenarios from lower-middle-
and upper-middle-income countries [2]. In order to
bridge the gaps in data, new country initiatives have
been undertaken, including improving the flow of infor-
mation in the HSTP and creating a vital events registra-
tion system; however, these initiatives may not be fully
functional for some time [2, 7, 11, 12]. Currently, the
existing data sources on mortality, morbidity, and health
risk factors are fragmented and are not systematically
analyzed locally, creating difficulties when describing key
performance indicators [13]. Meanwhile, estimating the
summary measures of health loss is essential in guiding
health systems and investments, and setting priorities,
especially when considering non-fatal consequences of
acute and chronic diseases and injury [14]. Disability-
adjusted life years (DALYs) are a summary measure that
combines mortality, morbidity, and disability to measure
population health [15]. This metric describes the causes
and drivers of mortality and morbidity in order to be
able to identify successes, unmet needs, and potentially
unrecognized emerging threats to population health
[16].
The Global Burden of Diseases, Injuries, and Risk Fac-
tors Study 2015 (GBD 2015) provides the most compre-
hensive source of DALY estimates for 195 countries,
including Ethiopia [15, 17]. We used GBD 2015 to
examine the burden of diseases and injuries from 1990
to 2015 in Ethiopia. We have demonstrated the ranks of
causes of age-standardized DALYs and the shift in ranks
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of different causes and described the relative burden of
communicable, maternal, neonatal, and nutritional dis-
orders (CMNN), non-communicable diseases, and injur-
ies. The findings will help measure the performances of
HSDP as well as set benchmarks and track HSTP pro-
gress in Ethiopia.
Methods
Data sources
GBD 2015 data were used to analyze DALYs for
Ethiopia. GBD uses all available data sources, meeting
quality criteria and rigorous analysis to estimate DALY
rates for 195 countries [16]. About 171 site-years of
cause of death data sources were used for Ethiopia to
provide national estimates, of which 70 were nationally
representative and 52 represented subnational locations
in Ethiopia. About 102 site-year data sources included
sibling history data, and 63 site-year data sources used
verbal autopsy data collection techniques [17]. For non-
fatal health outcome estimation, 489 site-year data
sources were used to generate national estimates for
Ethiopia. National representativeness was reported for
87 site-year non-fatal health outcome data sources, and
339 site-year data sources have unknown representative-
ness. Data were relatively scarce for Ethiopia. In this
case, GBD uses two more approaches to estimate cause
of death: identifying covariates for each cause and bor-
rowing strength from region and super-region in the
modeling process [18]. Approximately 881 site-year co-
variate data sources were used, from which 343 site-
years of data were nationally representative; the
remaining 538 were reported unknown. The full details
of data sources can be found in the supplementary
appendix [15].
Modeling
Years of life lost due to premature mortality (YLLs) and
years lived with disability (YLDs) were used to calculate
DALYs for the complete time-series 1990 to 2015
[16]. The GBD approach to estimate YLLs and YLDs
has been described in previous GBD publications [19,
20]. YLLs were computed by multiplying numbers of
deaths from each cause, in each age group, by the
reference life expectancy in order to measure the gap
between mortality rates and the reference life expect-
ancy [21]. YLDs were computed by multiplying the
prevalence of the condition with its corresponding
disability weight [22]. DALYs are the sum of YLLs
and YLDs [23, 24].
Causes of death by age, sex, and year were measured
primarily by using cause of death ensemble modeling
(CODEm) [11]. A detailed description of CODEm is re-
ported in previous GBD publications [11, 23]. In brief,
CODEm tests a wide range of models, such as mixed
effects linear models and spatiotemporal Gaussian
process regression (ST-GPR) models, and constructs an
ensemble model based on the performance of the differ-
ent models [23]. Out-of-sample predictive validity tests
were used to select the ensemble model to estimate
morality rates [23].
To estimate YLDs, GBD 2015 used a Bayesian meta-
regression method, DisMod-MR 2.1. It was designed to
address statistical challenges in the estimation of non-
fatal health outcomes, and for the synthesis of sparse
and heterogeneous epidemiological data. The sequence
of estimation occurs at five levels: global, super-region,
region, country, and, where applicable, subnational loca-
tions. At each level of the cascade, the DisMod-MR 2.1
computational engine enforces consistency between all
disease parameters [20]. For some of the diseases, nat-
ural history models, geospatial models, back-calculation
models, or registration completeness models were used.
Disability weights for 2337 sequelae of the 310 diseases
and injuries were used to capture the severity of health
loss. YLDs by cause at age, sex, country, and year levels
were adjusted for co-morbidity with simulation methods
[19, 24].
Interpretation of the results
We followed GBD categorization of diseases and injuries
to present and interpret the results. GBD uses a hier-
archy of causes that organizes 306 diseases and injuries
into four levels of categories [15]. The first level shows
three broad categories: communicable, maternal, neonatal,
and nutritional (CMNN) disorders; non-communicable
diseases (NCDs); and injuries. Level 2 has 21 mutually
exclusive and collectively exhaustive categories; Levels 3
and 4 have 164 and 255 categories, respectively [15]. We
present the results in terms of age-standardized DALY,
YLD, and YLL rates with 95% uncertainty intervals (UI)
[11, 14]. We report positive and negative percentages to
show changes from 1990 to 2015.
Results
Age-standardized disability-adjusted life years (DALYs)
The disease burden measured in DALYs for CMNN dis-
eases, non-communicable diseases, and injury categories
from 1990 to 2015 for both sexes and all ages in Ethiopia
is shown in Table 1 and Fig. 1.
All-cause age-standardized DALYs per 100,000 were
47,099.8 (95% UI, 36,546.7–60,314.2) in 2015. Of this
total, CMNN disorders caused 20,200.7 (95% UI,
16,532.2–24,917.9), NCDs caused 23,118.1 (95% UI,
17,124.4–30,579.6), and injuries caused 3781 (95% UI,
2642.9–5500.6) of the DALYs (Fig. 1). The percentage
contribution of CMNN diseases to total age-standardized
DALYs declined from 56% in 1990 to 43% in 2015, while
that of NCDs increased from 32% to 49% during the same
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period (Fig. 2). Age-standardized DALYs per 100,000 from
all-cause mortality declined from 1990 to 2015: rates of
DALYs caused by CMNN diseases declined from 61,403.3
to 20,200.7, DALY rates from NCDs declined from
34,790.3 to 20,200.7, and DALY rates due to injuries from
13,974.2 to 3781.0 (Fig. 1). The decreasing trend of DALY
rates over the years for the three broad categories contin-
ued with respect to age-standardized YLL rates, but the
same was not true for YLDs (Figs. 3, 4, and 5). Between
1990 and 2015, the contribution of age-standardized YLD
rates respective to DALY rates was higher for NCDs com-
pared to YLD rates due to CMNN diseases or injuries. In
2015, YLD rates contributed 36% of the total DALYs for
NCDs, and the rate was constant over the years.
Diarrhea, lower respiratory infections, and other infec-
tions combined caused 7953.5 (95% UI, 6112.7–10,309.1)
age-standardized DALYs per 100,000 in 2015. The age-
standardized DALY rate for HIV/AIDS and tuberculosis
combined was 4413.5 (95% UI, 3092.7–6109.8), and neo-
natal disorders caused 3296.7 (95% UI, 2873.9–3735.8)
DALYs per 100,000 (Table 1).
Cardiovascular diseases and neoplasms caused 6457.9
(95% UI, 4207.6–9509.3) and 3192.1 (95% UI, 1857.2–
5221.3) DALYs per 100,000, respectively (Table 1). Unin-
tentional and transport injuries caused 1214.6 (95% UI,
1017.4–1418) and 818.3 (95% UI, 520.2–1308.8) DALYs
per 100,000, respectively (Table 1).
From 1990 to 2015, all causes of DALYs except mus-
culoskeletal disorders showed declines, with a major re-
duction of age-standardized DALYs occurring within
CMNN group causes (Table 1). Age-standardized DALY
rates from diarrhea, lower respiratory infections, and
other infections collectively declined by 74%, the YLL
rate declined by 75%, and the YLD rate declined by 22%
during the 25-year period.
The combined age-standardized DALY rate from HIV/
AIDS and tuberculosis declined by 52% (Table 1), and
the reduction followed the YLL rate pattern of 53% more
closely than the YLD rate decline of 25%. The age-
standardized DALYs per 100,000 from cardiovascular
diseases and neoplasms showed 44% and 32% reduc-
tions in rate between 1990 and 2015, respectively.
The reduction in cardiovascular diseases and neo-
plasms was mainly from YLL rates, whereas the YLD
rates showed only a 7% reduction for neoplasms and
a 9% increase for cardiovascular diseases. Uninten-
tional injury declined by 53% and transport injury by
51% (Table 1). The YLL rate reduction was high for
transport and unintentional injuries compared with
their YLD rates.
Fig. 1 Levels and trends of age-standardized DALYs per 100,000 people by major causes for both sexes and all age groups with 95% UI in
Ethiopia, 1990–2015
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Ranks of specific diseases with their age-standardized
DALY rates and percentage changes between 1990 and
2015 are shown in Fig. 6. The top 20 leading causes of
age-standardized DALYs accounted for 59% of the total
DALYs in Ethiopia. Lower respiratory infections, diarrheal
diseases, and tuberculosis were the top three leading
causes of DALYs, accounting for 2998 (95% UI, 2173.7–
4029), 2592.5 (95% UI, 1850.7–3495.1), and 2562.9 (95%
UI, 1466.1–4220.7) per 100,000, respectively (Fig. 6). Is-
chemic heart disease and cerebrovascular disease were the
fourth and fifth leading causes of age-standardized DALY
rates, with 2535.7 (95% UI, 1603.7–3843.2) and 2159.9
Fig. 2 Percentage contribution to total age-standardized DALYs per 100,000 people for major causes for both sexes and all age groups in
Ethiopia, 1990–2015
Fig. 3 Levels of age-standardized YLLs, YLDs, and DALYs per 100,000 people due to communicable, maternal, neonatal, and nutritional diseases
for both sexes and all age groups in Ethiopia, 1990–2015
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(95% UI, 1369.7–3216.3), respectively. HIV/AIDS was the
sixth leading cause of DALYs, followed by diabetes melli-
tus and major depressive disorders.
Between 1990 and 2015, there was shifting in ranks of
disease types as certain non-communicable diseases
joined the top 20 causes, replacing most CMNN causes.
For example, measles, protein-energy malnutrition, and
malaria were among the top causes of age-standardized
DALYs in 1990 but not in 2015, as diabetes, low back
pain, and major depressive disorders ranked in the top
10 in 2015. Between 2005 and 2015, HIV/AIDS burden
decreased by 78% (Figs. 7, 8 and 9).
The top 30 leading causes of age-standardized DALY
rates showed reductions from 1990 to 2015 except low
back pain and sense organ diseases, as shown in Fig. 6.
Significantly larger reductions occurred in the first three
leading causes of DALYs: lower respiratory infections
decreased by 65%, diarrheal diseases decreased by 76%,
and tuberculosis decreased by 66% (Fig. 6). Ischemic
heart disease declined by 38% and cerebrovascular dis-
ease by 47% (Fig. 6). As presented in Fig. 6, most non-
communicable diseases in the 20 leading causes of
DALYs generally showed lower percentage declines com-
pared to CMNN diseases between 1990 and 2015. The
following causes showed reductions of 60% or more:
lower respiratory infections, diarrheal diseases, tubercu-
losis, neonatal encephalopathy, preterm birth complica-
tions, meningitis, malaria, protein-energy malnutrition,
iron-deficiency anemia, measles, war and legal interven-
tion, and maternal hemorrhage (Fig. 6).
The contribution of age-standardized YLL and YLD
rates to DALYs varies by diseases types over time. For
example, the reduction in age-standardized DALYs
from ischemic heart disease from 1990 to 2015
Fig. 4 Levels of age-standardized YLLs, YLDs, and DALYs per 100,000 people due to non-communicable diseases for both sexes and all age groups in
Ethiopia, 1990–2015
Fig. 5 Levels of age-standardized YLLs, YLDs and DALYs per 100,000 people due to injuries for both sexes and all age groups in Ethiopia, 1990–2015
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followed the YLL rate, declining by 39%, while the
YLD rate increased by 16%. The age-standardized
DALY rate due to cerebrovascular disease followed
the same pattern as its YLL rate; however, the YLD
rate increased by 21%. The same is true for diabetes
and congenital birth defects (Table 2). Similarly, the
age-standardized DALY rate for neonatal disorders
decreased, following the YLL rate pattern, as the YLD
rate increased. Neonatal encephalopathy showed a
50% decrease in the age-standardized YLL rate and a
30% increase in the YLD rate. Similarly, neonatal pre-
term birth complications showed a 60% decrease in
the DALY rate, while the YLD rate increased by 38%
between 1990 and 2015 (Table 2). The rate of decline
in DALYs per 100,000 was mainly due to a decrease
in YLLs rather than YLDs, similar to the leading
causes, lower respiratory infections, diarrheal diseases,
and tuberculosis.
Fig. 6 Ranks of causes of age-standardized DALYs per 100,000 for both sexes and all age groups in Ethiopia, 1990–2015
Fig. 7 Levels of age-standardized YLLs, YLDs, and DALYs per 100,000
people due to HIV/AIDS for both sexes and all age groups in
Ethiopia, 1990–2015
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Discussion
Comparing point estimates for Ethiopia in 2015, age-
standardized DALY rates caused by non-communicable
diseases were higher than those due to CMNN diseases.
Between 1990 and 2015 there was a larger decrease in
the DALY rate from CMNN diseases than from non-
communicable diseases between 1990 and 2015. The
higher reduction of DALY rates due to CMNN disorders
occurred following a major decline in premature mortal-
ity rates, as measured in age-standardized YLL rates;
however, the reduction of the age-standardized YLD rate
was minimal. Although the reduction in age-standardized
YLL rates caused non-communicable disease DALYs to
decline, the YLD rates did not decline proportionally.
Overall, the YLD rate contribution to total DALYs was
high, resulting in minimal reduction in DALYs caused by
non-communicable diseases over the 25-year period.
There are two possible explanations for the current bur-
den of non-communicable diseases in Ethiopia. The first
possibility is that the burden from non-communicable dis-
eases has truly increased and become highly prevalent in
urban settings due to behavior and lifestyle changes. The
other, however, postulates that non-communicable dis-
eases were existing problems and became more visible
with a greater reduction in CMNN diseases, increased
population size, and/or aging. The findings in this paper
could help to elucidate both possibilities; the absolute
number of DALYs due to non-communicable diseases has
increased and DALYs due to CMNN diseases decreased;
age-standardized DALYs, after controlling for population
Fig. 8 Levels of age-standardized YLLs, YLDs, and DALYs per 100,000 people due to diabetes for both sexes and all age groups in Ethiopia, 1990–2015
Fig. 9 Levels of age-standardized YLLs, YLDs, and DALYs per 100,000 people due to major depression for both sexes and all age groups
in Ethiopia, 1990–2015
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growth and aging, decreased over the 25 years in both
categories.
Age-standardized DALYs due to non-communicable
diseases declined slowly compared to CMNN diseases;
the YLD rate of non-communicable diseases was stable
over the last 25 years in Ethiopia. This could support the
fact that non-communicable diseases were not among
the country’s priorities as national strategies and action
plans were not in place until 2010 [25]. Moreover, the
age-standardized DALY rate reduction for CMNN dis-
eases was mainly driven by decreases in lower respira-
tory infections, diarrheal diseases, tuberculosis, measles,
malaria, protein-energy malnutrition, and others. These
findings support the direction and investment of the
health sector development plan in achieving the Millen-
nium Development Goals (MDGs) and other CMNN
disease targets for the last 25 years [1]. The plan appears
to be successful in reducing the burden of most CMNN
diseases and may address certain non-communicable
diseases with infectious disease origin, such as rheumatic
heart disease.
The findings of this study supported the claim made
in other studies about the double burden of CMNN dis-
ease and non-communicable diseases occurring in the
process of epidemiologic transition in Ethiopia [26–29].
However, there could be variation across different geog-
raphies and populations within the country. A rural-
based study showed that CMNN diseases constituted
72% of the total DALYs and NCDs contributed 24% [30].
It is challenging to compare this estimate with GBD
findings as there are methodological, study population,
and other major differences.
More specifically, lower respiratory infections, diar-
rheal diseases, and tuberculosis have continued to be
the three leading causes of age-standardized DALY
rates in 2015 as in 1990, although they showed re-
markable decline over the last 25 years. In addition,
the following leading diseases showed a reduction of
60% or more between 1990 and 2015: meningitis,
malaria, protein-energy malnutrition, iron-deficiency
anemia, measles, and maternal hemorrhage. This re-
duction in the leading causes of DALYs occurred fol-
lowing a reduction in premature mortality, as the
YLD rate contribution to the total DALY rate was
less.
The level of DALYs due to HIV/AIDS increased until
2005 and then decreased until 2015. This pattern was
highly influenced by the disease’s level and ability to
cause premature mortality over the years. In 2000, dis-
ability caused by HIV/AIDS, as measured by the age-
standardized YLD rate, peaked at 323 per 100,000 people
and declined to 100 per 100,000 in 2015. However, this
result may not be uniform across the different geo-
graphic and sociodemographic population groups in
Ethiopia. This requires improving equity and access to
antiretroviral therapy (ART) [31].
In contrast, age-standardized YLD rates caused by
neonatal disorders have increased over the years. For ex-
ample, rates of YLDs caused by neonatal encephalopathy
increased by 30%, and those caused by neonatal preterm
birth complications increased by 38% over the last
25 years. Although Ethiopia has achieved Millennium De-
velopment Goal 4 (MDG 4) of reducing child mortality,
reports showed that the decline in neonatal mortality was
not as impressive as that of infant and child mortality [32].
This implies that current national newborn survival strat-
egies, in the continuum of care approach, need to
prioritize the increasing trend of disabilities due to neo-
natal disorders in addition to premature mortality [32].
Except for the three leading causes of DALYs, the
other CMNN disease types that were leading causes in
the 1990s have been replaced by several non-
communicable diseases in 2015. The fourth and fifth
ranked causes of DALYs were ischemic heart disease and
cerebrovascular diseases. Both diseases caused increasing
rates of disability over the years. The same is true for
diabetes and congenital birth defects, as age-standardized
YLD rates increased between 1990 and 2015.
On the other hand, DALYs caused by major depressive
disorder were only from disability outcomes as measured
in age-standardized YLD rate, and that showed precisely
no change over the years. This finding might reflect the
fact that mental health was not in the priority national
health agenda until national mental health strategies
were developed in 2012 [33]. The integrated mental
health approach, which integrates mental health care
within existing primary care, needs to address the high
level of disabilities caused by major depressive disorder.
Implications of the findings for policies and practices
Primarily, the findings are useful for highlighting the
performance of the previous health sector development
plan and the MDGs, and to benchmark the health sector
transformation plan and the Sustainable Development
Goals at the country level [2, 34].
Improvements in common infectious diseases
Lower respiratory infections, diarrhea, and other com-
mon infectious diseases are still Ethiopia’s largest drivers
of premature death and disability as measured in DALY
rates; however, they are on the decline for all ages and
both sexes. The age-standardized DALY rate from these
diseases declined 74% between 1990 and 2015 (from
31,094 DALYs per 100,000 in 1990 to 7953 in 2015).
This decline has contributed to Ethiopia’s ability to
achieve MDG 4, reducing under-5 mortality by two-
thirds [13]. Many different types of interventions might
have impacted this decline: increased health service
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coverage and utilization for early detection and treat-
ment, community-based interventions under the flagship
of health extension workers, integrated management of
childhood illnesses, and increased childhood immuniza-
tions [35]. In spite of the ease with which these diseases
are preventable and treatable, the high rate of premature
deaths and disabilities due to common infectious dis-
eases is still unacceptably high in Ethiopia. There is a
need to scale up existing high-impact interventions,
especially in populations whose coverage lags behind the
target in skilled birth attendance and early postnatal
care, treatment interventions including oral rehydration
therapy and zinc, and antibiotics for pneumonia. There
is also a need to increase the coverage and utilization of
newly introduced interventions in the country, including
community management of childhood illness (pneumo-
nia, diarrhea, and malnutrition) neonatal sepsis, and
community-based nutrition, Interventions that improve
access to Haemophilus influenzae type b, pneumococcal,
and rotavirus vaccines, among others, could be imple-
mented to decrease the burden of these common infec-
tious diseases in Ethiopia [32].
Progress in combating HIV/AIDS, tuberculosis, and
malaria
Premature mortality and disability rates from malaria fell
drastically between 1990 and 2015, dropping 91% (from
1764 age-standardized DALYs per 100,000 in 1990 to
154 in 2015); however, HIV/AIDS and tuberculosis are
still Ethiopia’s leading drivers of premature mortality and
disability. Age-standardized DALY rates from HIV/AIDS
fell by 78% between 2005 and 2015 (from 8396 DALYs
per 100,000 in 2005 to 1850 in 2015), and the decline
followed the premature mortality rate trends. Country
progress reports indicate that HIV incidence has also de-
creased by 90% since 2005 [2].
The expansion of free antiretroviral treatment (ART)
since 2005 may have contributed to the reduction in
premature mortality rates in Ethiopia [36]. Some studies
also show that the decline in mortality among individ-
uals living with HIV/AIDS in Ethiopia is consistent with
ART uptake [36, 37]. However, the contribution of the
age-standardized disability rate (112 YLDs per 100,000)
to total DALYs was relatively small over the years com-
pared to premature mortality rates, and fell by 65% be-
tween 2005 and 2015. On the other hand, ART coverage
in adults (68%) and children (23%) is still very low in
Ethiopia, which contributes to premature mortality in
vulnerable populations [38]. Thus, improving universal
access to ART, retention of enrolled clients in treat-
ment services, and adherence to treatment are neces-
sary to reduce premature mortality from HIV/AIDS.
However, there is a need to seek strategies for the
sustainability of ART services in terms of funding for
Ethiopia. Prevention activities need to continue with a
focus on geographic “hot spots” and most at-risk
populations.
Although the total age-standardized DALY rate for tu-
berculosis (TB) decreased 65% between 1990 and 2015,
TB caused higher premature death and disability rates in
2015 (2563 age-standardized DALYs rate per 100,000
people). According to the 2014 WHO report, the preva-
lence and incidence of all forms of tuberculosis were 211
and 224 per 100,000 people, respectively [39]. Ethiopia is
one of the countries that has a high burden of HIV/tu-
berculosis co-infection as well as multidrug-resistant
tuberculosis. About 13% of all new tuberculosis cases
were HIV co-infected, and of all tuberculosis patients
with known HIV status, about 11% were HIV co-infected
[39]. According to the national tuberculosis drug resist-
ance surveillance report, 2.3% of new tuberculosis cases
and 17.8% of previously treated tuberculosis cases were
estimated to be multidrug-resistant [39]. There is a need
to address tuberculosis/HIV co-infection and multidrug-
resistant tuberculosis in order to improve the premature
mortality rate from tuberculosis in Ethiopia. This can be
done by increasing tuberculosis case detection rate
(74%), treatment success rate (83%), and tuberculosis
cure rate (67%) [2].
Increasing importance of non-communicable diseases
In 2015 cardiovascular diseases, cancer, diabetes, and
mental and substance use disorders accounted for 30%
of the total disease burden in the country as measured
in age-standardized DALY rates. Cardiovascular diseases,
including ischemic heart disease, stroke, and hyperten-
sive heart disease, were Ethiopia’s second leading cause
of premature death and disability (6458 age-standardized
DALYs per 100,000). Cancer was the sixth leading cause
of premature death and disability in 2015 (causing 3192
age-standardized DALYs per 100,000). Cervical, liver,
breast, and esophageal cancers are some of the leading
drivers of poor health from cancer. Mental and sub-
stance use disorders, including major depression, were
the seventh leading cause of premature death and dis-
ability (2224 DALYs per 100,000). In 2015, diabetes was
the ninth leading cause of premature death and disability
(causing 1106 DALYs per 100,000). A large percentage
of these non-communicable diseases are preventable
through the reduction of the four main shared behav-
ioral risk factors, all of which are widely prevalent in
Ethiopia: unhealthy diet, the harmful use of alcohol, to-
bacco use, and lack of physical activity [2]. Up to 80% of
heart disease, stroke, and type 2 diabetes, and about
40% of cancers could be prevented by controlling
these risk factors [40]. These behavioral risk factors
lead to more formidable metabolic risk factors, in-
cluding high blood pressure, high blood glucose, high
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blood lipids, overweight, and obesity [32]. High preva-
lence of overweight, obesity, and associated high
blood pressure were also reported in urban areas of
Ethiopia [29, 41].
In light of high disease burden from cardiovascular
disease, cancer, diabetes, mental and substance use
disorders in Ethiopia, and their shared behavioral risk
factors, prevention and treatment interventions need to
be reinforced and put in place at different levels. The
impact of these diseases and their risk factors could
affect sectors beyond health, and the response requires a
multi-sectoral approach. The health, agriculture, trade
and industry, education, urban planning, and transport
sectors need to be nationally coordinated to provide a
multi-sectoral response against the leading non-
communicable diseases. Initiatives to establish cancer
treatment centers, services for cardiovascular disease,
and mental illnesses need to be strengthened [2].
Ethiopia has already ratified the WHO Framework
Convention on Tobacco Control (FCTC) and the
Protocol to Eliminate Illicit Trade in Tobacco in 2015
[42]; however, there is a need to develop implementa-
tion guidelines and regulatory mechanisms that can
enforce the convention. Reducing tobacco use by
establishing tobacco-free environments, increasing public
knowledge of the hazards of tobacco, and continuously in-
creasing taxes on the purchase and sale of tobacco prod-
ucts are recommended interventions in the convention.
There is also a need to develop and implement guidelines
on alcohol use in Ethiopia.
Health services for cardiovascular diseases, cancers,
and diabetes need to be integrated within existing pri-
mary health care and extended to secondary and tertiary
health facilities. Preventive efforts on cervical cancer
screening, hypertension screening, diabetes screening,
and HBV vaccination need to be strengthened [2]. There
is also a need to involve the private sector and civic soci-
ety in delivering health services for cardiovascular dis-
ease, cancer, diabetes, and their risk factors. Besides,
institutional capacity developments and human resource
trainings, including pre-service and in-service trainings,
need to consider addressing the double burden of com-
mon infectious diseases (lower respiratory infections,
diarrheal disease), HIV/AIDS and tuberculosis, and
cardiovascular disease, cancer, and diabetes. The health
disparities between urban and rural populations and be-
tween subnational regional states and districts requires
further exploration to support public health policy at
each level.
Key investments for Ethiopia to reduce uncertainty
The 95% UI for premature death and disability estimates
varies by causes that positively or negatively affect health
policy debates and decisions for Ethiopia. The lack of
data is reflected by wider uncertainty intervals. For ex-
ample, 95% uncertainty intervals for estimates of age-
standardized DALYs per 100,000 for lower respiratory
infection, diarrhea, HIV/AIDS, tuberculosis, and malaria
showed relatively better uncertainties. However, uncer-
tainties for cardiovascular disease, 6457.9 (95% UI,
4207.6–9509.3) and cancer, 3192 (95% UI, 1857.2–5221.3),
estimates were massive, which could impact prioritization
and policy decisions. The uncertainties depend on the
availability and accuracy of data sources. Therefore, dis-
eases having wider uncertainty intervals require key
investments to generate comprehensive and quality
data. This concern has been apparent with most non-
communicable diseases.
Moreover, limitations of these estimates are discussed
widely and in detail in the published GBD 2015 articles;
however we summarized the relevant limitations here fo-
cusing on data sources [1, 5, 14, 24, 43]. The standard
GBD modeling assists in overcoming issues associated
with poor-quality data. First, there was lack of data from
Ethiopia, and making estimates for a country over time
is challenging with few or no data. There were relatively
more covariate data source inputs (881 site-years) than
non-fatal health outcomes (489 site-years) or causes of
death (171 site-years) in GBD 2015 to estimate burden
of disease for Ethiopia.
Almost all data sources for causes of death were verbal
autopsy and sibling history studies. Sibling history data
were nationally representative but were limited to mater-
nal health. Verbal autopsy data sources were all sub-
nationally representative and were used to provide
national estimates. In addition, there could be variations
within verbal autopsy data sources that could affect un-
certainty of national estimates [23]. Addressing and
reporting all age groups and all possible causes of death,
including non-communicable diseases, would be chal-
lenging for verbal autopsy data sources. In the non-fatal
outcome data sources, only 87 site-year data sources
were nationally representative and 339 site-years were
reported unknown, which could affect the uncertainty
level of the estimates. Moreover, data accessibility is a
critical challenge for which GBD 2015 estimates were
forced to use scientific literature that was not compre-
hensive and detailed in reporting. These sources re-
ported broad age categories, lacked reporting by sex,
and may have been influenced by other publication bias.
This resulted in exclusion of some data sources or
adjustment to a higher cause level. This requires close
collaboration using actual data sources to access com-
prehensive and detailed data for GBD estimates. All
these limitations with the different data sources may
have affected the uncertainty of the estimates.
Until good-quality vital statistics are attained for
Ethiopia, investing in national verbal autopsy studies,
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such as post-census or post-demographic health surveys,
and/or further expansion of demographic surveillance
sites, would assist in filling existing data gaps in Ethiopia.
There is a need to develop national data-sharing guide-
lines, a culture of data sharing, and a national data center
or data archive in the country. Studies should be released
in a timely manner to maximize their use.
Finally, Ethiopia requires high investment and com-
mitment to generate quality cause of death data
through Vital Events Registration Agency (VERA),
which was established in August 2016 [43]. There is
also a need to establish and strengthen surveillance sys-
tems and surveys to generate national and subnational
non-fatal health outcome data with emphasis on lead-
ing non-communicable diseases and their shared risk
factors. Estimates did not show the possible heteroge-
neous figures on diseases and disorders by rural and
urban or subnational populations as sociodemo-
graphic, lifestyle, and health risk factors, which may
vary [2, 15]. Therefore, subnational regional states could
benefit from subnational burden of disease estimates in the
future.
Conclusions
Ethiopia has been successful in reducing age-standardized
DALYs related to most communicable, maternal, neonatal,
and nutritional deficiency diseases for the last 25 years.
This has resulted in a shift in the leading causes of DALYs
from CMNN disorders to non-communicable diseases be-
tween 1990 and 2015. Lower respiratory infections, diar-
rheal diseases, and tuberculosis were still leading causes of
premature death and disability in 2015 despite major re-
ductions. Increasing trends of disabilities due to neonatal
encephalopathy, neonatal preterm birth complications,
and neonatal disorders should be emphasized in the na-
tional newborn survival strategy. Premature mortality
caused by non-communicable diseases showed reduc-
tions, although disability rates did not decline. Be-
cause of this, integrated strategies in the health
system and a multi-sectoral response should be
enacted. Strategies for non-communicable diseases
need to focus on the leading causes, such as cardio-
vascular diseases, cancer, diabetes, and mental and
substance use disorders. Generating quality data
through new initiatives such as vital events registra-
tion, surveillance programs, and surveys should be a
priority. There should also be a data-sharing mechan-
ism to pool multiple data sources together to answer
national and subnational health indicators. Moreover,
there is a need to measure disease burden at subna-
tional regional state levels and identify variations with
urban and rural populations to support health policy in
Ethiopia.
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